Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Diamyd Medical Ab Stock

Price
Target price
€0.90

€0.90

1.120%
0.01
1.120%
-
 
06.05.24 / Frankfurt WKN: A1T90L / Name: Diamyd Medical Ab / Stock / ? /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Diamyd Medical Ab in the next few years
Wizard

Diamyd Medical Ab Stock

Diamyd Medical Ab gained 1.120% today.
Our community identified positive and negative aspects for Diamyd Medical Ab stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Diamyd Medical Ab stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
What does Diamyd Medical Ab do?

Pros and Cons of Diamyd Medical Ab in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-13

Upon initial review of the financial statements of Diamyd Medical Ab, it appears that the company has experienced some fluctuations in its financial performance over the past few years. The overall trend seems to be an increase in total assets and equity, while also experiencing some changes in cash flow and net income. A more detailed analysis is necessary to determine the strengths, weaknesses, and potential areas of improvement for the company.

Increasing Total Assets: Diamyd Medical Ab's total assets have grown from SEK 89.76 million in 2020 to SEK 236.52 million in 2022. This indicates that the company has been expanding its resources and investments, which may contribute to future growth.

Growing Stockholder Equity: The company's stockholder equity has also increased consistently over the past few years, from SEK 72.49 million in 2020 to SEK 214.38 million in 2022. This growth in stockholder equity signifies a strengthening of the company's financial position and may signal increased shareholder confidence.

Show more
Register To Post